Cancer / Oncology
Zelgen and 111, Inc. to Develop a New Management Platform for Liver Cancer Patients in China
111, Inc. , a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in&nb...
August 04, 2021 | News
FDA Clears Promega OncoMate™ MSI Dx Analysis System
Microsatellite instability (MSI) is a form of genomic instability caused when too many or too few repeating bases, called microsatellites, occur during DNA...
July 30, 2021 | News
Clarity commences theranostic prostate cancer trial
Clarity's Executive Chairman, Dr Alan Taylor, commented, "The prostate cancer market is a key focus for Clarity and we are very pleased to commence th...
July 29, 2021 | News
Zhongchao To Promote the Equalization of Breast Cancer Diagnosis
Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a healthcare services company offering patient management, online healthcare information, pro...
July 28, 2021 | News
LISCure, the first Korean biotech company receiving equity investment from Mayo Clinic
LISCure Biosciences, Inc. ("LISCure") has entered into a know-how license and development collaboration agreement, and stock purchase agreement with Mayo C...
July 26, 2021 | News
Elekta Unity to advance precision radiation medicine
Presentation of 36 abstracts underscore the potential of Elekta Unity to advance precision radiation medicine Elekta (EKTA-B.ST) today announced the prese...
July 23, 2021 | News
Stimulating blood vessel formation with magnets
Magnetic field can be used to stimulate blood vessel growth, according to a study published in the journal Science and Technology of Advanced Materials. Th...
July 22, 2021 | News
Terumo and UMCU to develop solutions in Interventional Oncology
Terumo Europe and University Medical Center Utrecht (UMC Utrecht) announced today that they signed a Memorandum of Understanding (MoU) to recognize the lon...
July 21, 2021 | News
Konyang University Hospital in South Korea relies on Molecular Health's MH Guide for personalized cancer medicine
It makes Konyang University Hospital the first facility in South Korea to use MH Guide. "Precision medicine in cancer care enables personalized treat...
July 16, 2021 | News
MiRXES Secures US$77 Million To Accelerate Multi-Cancer Early Detection
MiRXES Pte Ltd, a biotechnology company focused on improving and saving lives with RNA-powered disease early detection tests, announced today it has ...
July 12, 2021 | News
Elekta optimizes treatment times for cancer patients
For the last several years, Elekta (EKTA-B.ST) has invested substantially in digitized service solutions to keep critical treatment machines up and running...
July 07, 2021 | News
Y-Biologics & Pierre Fabre enter into an agreement in the field of immuno-oncology
These antibodies have been functionally validated by the Pierre Fabre R&D teams for their specific properties on a pivotal immuno-oncology target actin...
July 06, 2021 | News
BioMed X & Merck KGaA, Darmstad Launch New Research Program in Oncology
BioMed X Institute expands its collaboration with Merck KGaA, Darmstadt, Germany to a total of eight research programs. Call for application of ...
July 05, 2021 | News
QIAGEN Forms Strategic Alliance With Sysmex Corporation
Frankfurt Prime Standard:QIA) today announced a global strategic alliance with Japan’s Sysmex Corporation (Tokyo Stock Exchange, First Section [Ticke...
July 02, 2021 | News
Most Read
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
